Substacks recommended by The M&A Hunter

Recommended by The M&A Hunter

Joe Duarte is author of the Best Seller "Options Trading for Dummies." Stock market analysis for active traders and long term investors. Buy/Sell strategies for stocks, options, and ETFs.

BioEquity Watch

BioEquity Watch is a free, independent publication offering in-depth analysis of biotech and pharmaceutical companies, focused on market-relevant research, IPOs, and drug development pipelines.

Macro Mornings 💡

By Alessandro (Macro Strategist)

Macro Mornings is a Top 1% investing newsletter globally, delivering investment strategies and macroeconomic trend analysis. Get weekly updates with clear and concise summaries of the most important market news.

Hataf Capital

By Talha Quraishi

We bring a rigorous research-driven approach to uncovering high-conviction stocks with compelling growth potential across dynamic sectors like big tech, semiconductors, AI, and healthcare. Leveraging comprehensive sector insights, We analyze both low-risk

Joe’s Weekender Portfolio Substack

By Joe Duarte

Long term stock picks from Joe Duarte.

HalfBakedInnovations

By Biotech Distilled

The Market Dispatch

Monthly, data-driven insights on U.S. equities and macro trends — clear, concise, and actionable.

Jim Melvin's Realms of Fantasy

I am a novelist whose main focus is epic and dark fantasy but who also writes a wide range of fiction and nonfiction. Please sign up to receive my free newsletter.

The Stock Lab

By thrillful

I build stock analysis tools. This Substack documents the process: ideas, data sources, models, failures, and experiments — starting with risk analysis, but not ending there.

Ear's Substack

By EarAche

My personal Substack

Alpha Talon Investment Research

By AT Investment Research

Alpha Talon Investment Research Limited is a Hong Kong based private family office deploying proprietary capital with a focus on biotech and catalyst-driven fundamental investing.

The Tactical Allocation Letter

By Tactical Allocation Desk

A disciplined, data-driven strategy allocating tactically UPRO, Bitcoin, and Gold to minimize drawdowns and maximize returns.

World Politics

Hard-hitting analysis of the top stories across the globe

The Wealth Management Experience

By Matthew Curran

Where elite advisors refine how they sell, operate, show up, and serve.

TopStocksTrader Newsletter

Welcome to our publication which offers investment ideas in today's dynamic markets. Our subscription rates are very low; offering the best value for the individual investor. With weekly 100% winners; you could earn back your cost in a single trade!

Clinical Catalysts

By Harry

Breaking down the science and strategy behind pharma market movers. Not financial advice.

The Pharma Fox’s Substack

My personal Substack

Alts.co

By Stefan

Unique investment ideas worth exploring.

Madrina Molly: Wisdom for Women of a Certain Age(ncy)®

By Sherry Finkel Murphy

Financial and Longevity Planning Education By Sherry Finkel Murphy, CFP®, RICP®, ChFC®, Founder

Helix

By Sowmy VJ

Helix Research (London): Exploiting Mispriced Balance Sheet Resilience. Rules based. High conviction core. Structured pipeline. Profit first. Listed equities only.

Dr. Corey Babb

Board-certified gynecologist specializing in menopause and female sexual medicine. Here, I evaluate women’s health and biopharma companies through a clinician-investor lens.

Uglitteringgoose

On Substack

By Substack Team

Resources, stories, and news for the writers, podcasters, musicians, video creators, and culture makers publishing on Substack.

"I'm a biotech investor who became obsessed with understanding why certain companies get acquired while others don't. After spotting Performance Healthcare months before their acquisition, I realized the patterns were repeatable. This newsletter documents that research."

- The M&A Hunter

Dividend Stock Guru

By Michael Letcher

We can help you double your investment returns using high-yield dividend stocks instead of CDs and high-yield savings accounts. Don’t wait for CDs to mature or for a growth stock to pop. Subscribe now and master higher yields with confidence!

Ezra's Notes

By Ezra Crangle

Thoughts on investing and companies from a long-term perspective

The Intrepid Investor's Guidebook

By C Scott Garliss

Harness the same analysis fund managers pay me $20,000/year to access. I spent over two decades helping some of the world’s largest mutual and hedge funds invest by making the complicated simple.

Fundless Analyst

Fundamental research, general investment thoughts, and the occasional Buffett quote.

Fulcrum Insights

Independent Market Analysis

The Financial Pen

I capture flashes of market insight before they fade and share them here. Expect weekly U.S./Asia stock ideas (with my positioning), idea follow-ups, and occasional thought experiments or hidden gems from investing legends.